WallStreetZenWallStreetZen

NASDAQ: TVTX
Travere Therapeutics Inc Stock Ownership - Who owns Travere Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Travere Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jeffrey A. MecklerDirector2026-09-1014,000$67.46
$944.48kSell
Jeffrey A. MecklerDirector2026-09-1010,000$26.52
$265.20kBuy
Jeffrey A. MecklerDirector2026-09-101,700$65.39
$111.17kSell
Jeffrey A. MecklerDirector2026-09-101,200$66.15
$79.38kSell
Jeffrey A. MecklerDirector2026-09-1010,000$17.44
$174.40kBuy
Jeffrey A. MecklerDirector2026-09-103,100$68.09
$211.07kSell
Christopher R. ClineCFO2026-09-02642$66.37
$42.61kSell
Gary A. LyonsDirector2026-08-185,000$17.44
$87.20kBuy
Gary A. LyonsDirector2026-08-18900$63.86
$57.47kSell
Gary A. LyonsDirector2026-08-184,100$63.27
$259.39kSell

1 of 14

TVTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TVTX insiders and whales buy or sell their stock.

TVTX Shareholders

What type of owners hold Travere Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ruth Shepley51.98%49,000,000$3.22BInsider
Broadfin Healthcare Master Fund Ltd2.82%2,658,854$174.93MInsider
Opaleye GP LLC2.23%2,097,671$138.01MInsider
Martin Shkreli1.87%1,765,168$116.13MInsider
Eric M. Dube0.46%432,886$28.48MInsider
Marc L. Panoff0.23%221,100$14.55MInsider
Steve Aselage0.18%166,419$10.95MInsider
Alvin Shih0.17%158,334$10.42MInsider
Peter Heerma0.15%140,684$9.26MInsider
Christopher R. Cline0.13%118,016$7.76MInsider

1 of 3

TVTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TVTX0.11%61.61%Net SellingNet Selling
KNSA0.06%10.48%Net SellingNet Selling
DNTH0.12%60.34%Net BuyingNet Buying
SRRK0.11%67.14%Net BuyingNet Selling
MIRM0.11%81.26%Net BuyingNet Selling
View Top Biotech Stocks

Travere Therapeutics Stock Ownership FAQ

Who owns Travere Therapeutics?

Travere Therapeutics (NASDAQ: TVTX) is owned by 0.11% institutional shareholders, 61.61% Travere Therapeutics insiders, and 38.28% retail investors. Ruth Shepley is the largest individual Travere Therapeutics shareholder, owning 49.00M shares representing 51.98% of the company. Ruth Shepley's Travere Therapeutics shares are currently valued at $3.06B.

If you're new to stock investing, here's how to buy Travere Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.